Concepedia

Author

M Harzic

Centre Hospitalier de Versailles

Also Known As

M HARZIC, M Harzic, M. Harzic, Martine Harzic

44

Publications

1.4K

Citations

17

H-Index

7

Concepts

All Affiliations

Centre Hospitalier de VersaillesInsermHôpital PellegrinInstitut Necker Enfants MaladesHôpital Necker-Enfants Malades
MH

About

M Harzic is an author at Centre Hospitalier de Versailles specializing in immunology, hiv, and virology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

232

2

Immunology

2

2

232

3

Hiv

2

2

232

4

Autoimmunity

1

1

88

5

Immunotherapy

1

1

88

M Harzic

×

15

Publications

1.1K

Citations

15

H-Index

YearCitations

LYMPHADENOPATHY-ASSOCIATED VIRUS TYPE 2 IN AIDS AND AIDS-RELATED COMPLEX

Françoise Brun‐Vézinet, Christine Katlama, Dominique Roulot,

The Lancet

1987

144

Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy

Nicole Ngo‐Giang‐Huong, Christiane Deveau, I. Da Silva,

AIDS

2001

124

French National Sentinel Survey of Antiretroviral Drug Resistance in Patients With HIV-1 Primary Infection and in Antiretroviral-Naive Chronically Infected Patients in 2001-2002

Diane Descamps, Marie‐Laure Chaix, Patrice André,

JAIDS Journal of Acquired Immune Deficiency Syndromes

2005

124

Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France

Marie‐Laure Chaix, Diane Descamps, M Harzic,

AIDS

2003

113

HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time

Jade Ghosn, Isabelle Pellegrin, Cécile Goujard,

AIDS

2006

107

Evolution of Cytotoxic T Lymphocyte Responses to Human Immunodeficiency Virus Type 1 in Patients with Symptomatic Primary Infection Receiving Antiretroviral Triple Therapy

Marc Dalod, M Harzic, Isabelle Pellegrin,

The Journal of Infectious Diseases

1998

88

Highly Active Antiretroviral Treatment Initiated Early in the Course of Symptomatic Primary HIV‐1 Infection: Results of the ANRS 053 Trial

Bruno Hoen, Béatrice Dumon, M Harzic,

The Journal of Infectious Diseases

1999

76

Predictive value of cytomegalovirus viraemia for the occurrence of CMV organ involvement in AIDS

Dominique Salmon, F. Lacassin, M Harzic,

Journal of Medical Virology

1990

61

Cytomegalovirus colitis in HIV-1-infected patients

Hervé Mentec, Catherine Leport, J Leport,

AIDS

1994

49

Cell-associated HIV-1-DNA quantitation after highly active antiretroviral therapy-treated primary infection in patients with persistently undetectable plasma HIV-1 RNA

Isabelle Garrigue, Isabelle Pellegrin, Bruno Hoën,

AIDS

2000

45

Page 1